Latest Avascular necrosis Stories
OTTAWA, Oct. 30, 2014 /CNW Telbec/ - Health Canada today released the October 2014 issue of the Canadian Adverse Reaction Newsletter (CARN).
ROSEMONT, Ill., June 18, 2014 /PRNewswire-USNewswire/ -- A new position paper on Medication Related Osteonecrosis of the Jaw (MRONJ) released by the American Association of Oral and Maxillofacial Surgeons,
d'Oliveira & Associates has released a new infographic detailing the possible risks of Fosamax, including femur fractures and osteonecrosis of the jaw. (PRWEB)
Law firm offers no win - no fee promise for clients injured from the drug Fosamax, used to treat bone-weakening diseases.
Estate of Fosamax User Who Developed Osteonecrosis of the Jaw Reaches Confidential “Stipulation Agreement” with Merck on Damages. Melville, NY (PRWEB) October
Parker Waichman LLP has filed a lawsuit on behalf of a woman who suffered a left atypical femur fracture, allegedly due to using Fosamax (alendronate).
Regenerative medicine is now being used for treatment of Avascular Necrosis, according to A. J.
A study published online in May 2012, by the Archives of Internal Medicine, a publication of the American Medical Association, revealed that atypical femoral fractures were associated with bisphosphonate
Ennis & Ennis, PA Summarizes the Latest Fosamax Study that Confirms Long-Term Use of Biphosphonates, such as Fosamax and Boniva, Causes Atypical Femur Fractures (PRWEB)
- Growing in low tufty patches.